Hangzhou Coco Healthcare Products Co.Ltd. (301009) - Total Assets
Based on the latest financial reports, Hangzhou Coco Healthcare Products Co.Ltd. (301009) holds total assets worth CN¥2.15 Billion CNY (≈ $314.74 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See net assets of Hangzhou Coco Healthcare Products Co.Ltd for net asset value and shareholders' equity analysis.
Hangzhou Coco Healthcare Products Co.Ltd. - Total Assets Trend (2017–2024)
This chart illustrates how Hangzhou Coco Healthcare Products Co.Ltd.'s total assets have evolved over time, based on quarterly financial data.
Hangzhou Coco Healthcare Products Co.Ltd. - Asset Composition Analysis
Current Asset Composition (December 2024)
Hangzhou Coco Healthcare Products Co.Ltd.'s total assets of CN¥2.15 Billion consist of 61.1% current assets and 39.0% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 29.4% |
| Accounts Receivable | CN¥230.47 Million | 11.0% |
| Inventory | CN¥141.88 Million | 6.8% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥81.68 Million | 3.9% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2017–2024)
This chart illustrates how Hangzhou Coco Healthcare Products Co.Ltd.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see 301009 company net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Hangzhou Coco Healthcare Products Co.Ltd.'s current assets represent 61.1% of total assets in 2024, an increase from 58.1% in 2017.
- Cash Position: Cash and equivalents constituted 29.4% of total assets in 2024, up from 25.5% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, a decrease from 4.0% in 2017.
- Asset Diversification: The largest asset category is accounts receivable at 11.0% of total assets.
Hangzhou Coco Healthcare Products Co.Ltd. Competitors by Total Assets
Key competitors of Hangzhou Coco Healthcare Products Co.Ltd. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Silicon2 Co. Ltd.
KQ:257720
|
Korea | ₩668.12 Billion |
|
Guangdong Marubi Biotechnology Co
SHG:603983
|
China | CN¥4.85 Billion |
|
Profit Cultural & Creative Group Co Ltd
SHE:300640
|
China | CN¥1.12 Billion |
|
Kolmar BNH Co. Ltd
KQ:200130
|
Korea | ₩649.69 Billion |
|
Amorepacific Group
KO:002795
|
Korea | ₩8.54 Trillion |
|
Hankook Cosmet
KO:123690
|
Korea | ₩57.42 Billion |
|
KP Tissue Inc
TO:KPT
|
Canada | CA$71.60 Million |
|
Suominen Oyj
HE:SUY1V
|
Finland | €278.77 Million |
Hangzhou Coco Healthcare Products Co.Ltd. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.99 | 2.51 | 1.05 |
| Quick Ratio | 1.77 | 2.23 | 0.90 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥684.27 Million | CN¥673.28 Million | CN¥43.81 Million |
Hangzhou Coco Healthcare Products Co.Ltd. - Advanced Valuation Insights
This section examines the relationship between Hangzhou Coco Healthcare Products Co.Ltd.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.50 |
| Latest Market Cap to Assets Ratio | 0.22 |
| Asset Growth Rate (YoY) | 4.9% |
| Total Assets | CN¥2.09 Billion |
| Market Capitalization | $449.53 Million USD |
Valuation Analysis
Below Book Valuation: The market values Hangzhou Coco Healthcare Products Co.Ltd.'s assets below their book value (0.22x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Hangzhou Coco Healthcare Products Co.Ltd.'s assets grew by 4.9% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Hangzhou Coco Healthcare Products Co.Ltd. (2017–2024)
The table below shows the annual total assets of Hangzhou Coco Healthcare Products Co.Ltd. from 2017 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥2.09 Billion ≈ $305.77 Million |
+4.90% |
| 2023-12-31 | CN¥1.99 Billion ≈ $291.49 Million |
+2.23% |
| 2022-12-31 | CN¥1.95 Billion ≈ $285.15 Million |
-6.57% |
| 2021-12-31 | CN¥2.09 Billion ≈ $305.19 Million |
+39.60% |
| 2020-12-31 | CN¥1.49 Billion ≈ $218.61 Million |
+39.37% |
| 2019-12-31 | CN¥1.07 Billion ≈ $156.86 Million |
+7.59% |
| 2018-12-31 | CN¥996.27 Million ≈ $145.79 Million |
+4.09% |
| 2017-12-31 | CN¥957.14 Million ≈ $140.06 Million |
-- |
About Hangzhou Coco Healthcare Products Co.Ltd.
Hangzhou Coco Healthcare Products Co.,Ltd. engages in the research, development, production, and sale of baby care, adult incontinence, and pet hygiene products in China and internationally. It offers adult incontinence products, including adult diapers, adult pull-up pants, nursing pads, maternity towels, menstrual pants, absorbent towels, and other products, as well as feminine, cleaning, famil… Read more